Pfizer share news, announcements and annual reports
NSE: PFIZERBSE: 500680Pharmaceuticals & BiotechnologySmall Cap
Pfizer Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 1966 on BSE, Apr 1999 on NSE
Last close ₹3,687.80down ₹72.00 (1.92%)BSE ₹3,687.05
Share price at the NSE close on 30 Oct 2026. Previous close ₹3,759.80.
30 Oct: open ₹3,760.00, high ₹3,776.90, low ₹3,668.10
52-week range of traded prices to 30 Oct 2026
₹3,589.00Low, 23 Oct 2026₹5,346.00High, 30 Oct 2025
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹16,871 Cr327th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 22.95
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.01
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.03%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 21.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 17,12450.8% delivered
Pfizer analyst meets
42 filed, newest first.
Aug 2020
6 Aug · Analysts
4 Aug · Analysts
Nov 2019
12 Nov · Analysts
6 Nov · Analysts
5 Nov · Analysts
Sep 2019
16 Sep · Analysts
16 Sep · Analysts
Aug 2019
28 Aug · Analysts
19 Aug · Analysts
Jan 2019
29 Jan · Analysts
29 Jan · Analysts
Nov 2018
27 Nov · Analysts
19 Nov · Analysts
Jun 2018
20 Jun · Analysts
Mar 2018
19 Mar · Analysts
19 Mar · Analysts
16 Mar · Analysts
Dec 2017
7 Dec · Analysts
Sep 2017
7 Sep · Analysts
Aug 2017
24 Aug · Analysts
17 Aug · Analysts
16 Aug · Analysts
May 2017
29 May · Analysts
19 May · Analysts
17 May · Analysts
Feb 2017
2 Feb · Analysts
Jan 2017
30 Jan · Analysts
11 Jan · Analysts
Dec 2016
8 Dec · Analysts
Nov 2016
8 Nov · Analysts
4 Nov · Analysts
Sep 2016
22 Sep · Analysts
Aug 2016
Jun 2016
May 2016
20 May · Analysts
Apr 2016
13 Apr · Analysts
Mar 2016
30 Mar · Analysts
9 Mar · Analysts
Feb 2016